HealthStream, Inc. (HSTM) — Fair Value Analysis

Base-case fair value (P50): $30.28 · Current price: $28.46 · Verdict: Fairly Valued

The Verdict on HSTM

HEALTHSTREAM INC (HSTM) currently trades at $28.46, landing it squarely in our "Fairly Valued" category based on rigorous Monte Carlo simulations. Our median fair value (P50) analysis for HSTM, derived from thousands of forward-looking scenarios, robustly pegs the intrinsic value at $30.28. This specific figure translates to a potential upside of +6.4% from the present market price, indicating that the market is largely efficient in its assessment of HSTM's intrinsic value. This outcome suggests that HSTM is neither significantly undervalued nor significantly overvalued, aligning closely with its projected financial trajectory.

How HSTM stacks up against peers

HSTM is assigned an "average" quality tier, a designation reflecting its operational and financial health when benchmarked against its sector peers. This crucial quality assessment is deeply integrated into our Monte Carlo simulations, influencing the probable distribution of HSTM's fair value. While the stock's current price of $28.46 is in close alignment with our median fair value of $30.28, the "average" quality tier signals a balanced risk-reward profile. This implies HSTM lacks the inherent resilience often seen in "strong" quality companies but also avoids the elevated risks associated with "weak" quality firms. The modest +6.4% should be viewed within this context of its average standing.

What this means for investors

For investors evaluating HEALTHSTREAM INC (HSTM), the "Fairly Valued" verdict is a key takeaway. With a current price of $28.46 and a median fair value of $30.28, the implied +6.4% suggests a market that has largely digested HSTM's known fundamentals. The "average" quality tier further reinforces the expectation of steady, rather than dramatic, performance. Significant shifts in valuation, either up or down, would likely stem from unforeseen fundamental developments or substantial changes in the broader market environment, rather than a current mispricing. To gain deeper insight into HSTM’s full Monte Carlo distribution, including detailed bear and bull case scenarios and their probability weightings, we invite you to sign up for a free FairCurve account.

Frequently Asked Questions

Is HSTM overvalued or undervalued right now?

Based on our Monte Carlo simulations, HEALTHSTREAM INC (HSTM) is currently "Fairly Valued". Its median fair value (P50) of $30.28 is very close to its current market price of $28.46.

What is the bear case and bull case for HSTM?

The full Monte Carlo distribution, which includes specific bear (P10) and bull (P90) target prices along with the probability of achieving upside, is exclusively available to FairCurve account holders. Sign up for free to access these detailed scenarios.

How does FairCurve calculate HSTM's fair value?

FairCurve determines HSTM's fair value using sophisticated Monte Carlo simulations, modeling thousands of potential forward-looking scenarios to project a comprehensive probability distribution of its intrinsic value.

How can I track HSTM's fair value as it changes?

You can add HSTM to a free FairCurve watchlist to receive daily fair-value updates. Your watchlisted stocks are also instantly re-valued when new earnings or significant fundamental data are released.